Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polymorphism, Single Nucleotide | 81 | 2024 | 16045 | 2.350 |
Why?
|
Stomach Neoplasms | 25 | 2022 | 1481 | 2.270 |
Why?
|
Colorectal Neoplasms | 42 | 2024 | 6974 | 1.820 |
Why?
|
Urinary Bladder Neoplasms | 21 | 2024 | 2195 | 1.700 |
Why?
|
MicroRNAs | 19 | 2023 | 3803 | 1.330 |
Why?
|
Genetic Predisposition to Disease | 58 | 2024 | 18065 | 1.190 |
Why?
|
Genome-Wide Association Study | 37 | 2024 | 12795 | 0.950 |
Why?
|
Case-Control Studies | 52 | 2024 | 22291 | 0.700 |
Why?
|
China | 21 | 2024 | 2395 | 0.680 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2022 | 325 | 0.650 |
Why?
|
Body Fluids | 1 | 2021 | 321 | 0.640 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 872 | 0.630 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8647 | 0.590 |
Why?
|
Adenosine | 5 | 2024 | 820 | 0.570 |
Why?
|
Quantitative Trait Loci | 13 | 2024 | 2131 | 0.560 |
Why?
|
Lung Neoplasms | 12 | 2024 | 13586 | 0.530 |
Why?
|
Genotype | 30 | 2024 | 13045 | 0.470 |
Why?
|
Genetic Association Studies | 10 | 2021 | 2744 | 0.450 |
Why?
|
Promoter Regions, Genetic | 12 | 2020 | 5797 | 0.430 |
Why?
|
Carcinogens | 3 | 2024 | 453 | 0.430 |
Why?
|
Particulate Matter | 10 | 2023 | 2617 | 0.420 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5432 | 0.410 |
Why?
|
Genetic Variation | 11 | 2021 | 6611 | 0.390 |
Why?
|
Prognosis | 34 | 2024 | 30010 | 0.390 |
Why?
|
Mendelian Randomization Analysis | 6 | 2023 | 1040 | 0.390 |
Why?
|
Genomics | 4 | 2024 | 5926 | 0.380 |
Why?
|
RNA, Small Interfering | 4 | 2024 | 3428 | 0.380 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1206 | 0.380 |
Why?
|
Humans | 155 | 2024 | 768166 | 0.370 |
Why?
|
Alleles | 15 | 2024 | 6894 | 0.350 |
Why?
|
Homeodomain Proteins | 2 | 2015 | 2429 | 0.320 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 793 | 0.310 |
Why?
|
Male | 90 | 2024 | 364719 | 0.300 |
Why?
|
Colonic Neoplasms | 4 | 2024 | 2541 | 0.300 |
Why?
|
Nephrolithiasis | 2 | 2022 | 117 | 0.290 |
Why?
|
DNA Methylation | 7 | 2021 | 4428 | 0.290 |
Why?
|
Methyltransferases | 4 | 2023 | 373 | 0.290 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11101 | 0.280 |
Why?
|
ROC Curve | 8 | 2021 | 3628 | 0.280 |
Why?
|
Middle Aged | 64 | 2024 | 223492 | 0.280 |
Why?
|
Female | 89 | 2024 | 397192 | 0.270 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3187 | 0.270 |
Why?
|
Autophagy | 3 | 2024 | 1349 | 0.270 |
Why?
|
Area Under Curve | 5 | 2021 | 1643 | 0.270 |
Why?
|
CpG Islands | 3 | 2020 | 1208 | 0.270 |
Why?
|
DNA Damage | 4 | 2020 | 2469 | 0.260 |
Why?
|
Organic Cation Transport Proteins | 2 | 2019 | 61 | 0.260 |
Why?
|
Neoplasms | 8 | 2024 | 22371 | 0.260 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3948 | 0.250 |
Why?
|
Exosomes | 2 | 2022 | 422 | 0.250 |
Why?
|
Risk Factors | 31 | 2024 | 74944 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2024 | 1560 | 0.250 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4282 | 0.240 |
Why?
|
Cell Proliferation | 9 | 2022 | 10474 | 0.240 |
Why?
|
Endonucleases | 2 | 2020 | 371 | 0.240 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2024 | 43 | 0.240 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2024 | 45 | 0.240 |
Why?
|
Glucuronosyltransferase | 2 | 2024 | 136 | 0.230 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 2 | 2022 | 58 | 0.230 |
Why?
|
Aged | 48 | 2024 | 171504 | 0.230 |
Why?
|
Environmental Pollutants | 2 | 2024 | 1296 | 0.230 |
Why?
|
Air Pollution | 3 | 2024 | 2374 | 0.220 |
Why?
|
Survival Analysis | 13 | 2021 | 10101 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2810 | 0.210 |
Why?
|
Cell Line, Tumor | 13 | 2024 | 17140 | 0.210 |
Why?
|
Environmental Exposure | 7 | 2024 | 4543 | 0.210 |
Why?
|
Air Pollutants | 4 | 2024 | 2916 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
Transcription Factors | 5 | 2024 | 12168 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2024 | 423 | 0.190 |
Why?
|
3' Untranslated Regions | 4 | 2018 | 515 | 0.190 |
Why?
|
Databases, Genetic | 4 | 2021 | 1758 | 0.190 |
Why?
|
Peroxisomes | 1 | 2022 | 67 | 0.190 |
Why?
|
Smoking | 6 | 2024 | 9092 | 0.190 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2022 | 116 | 0.190 |
Why?
|
Neoplasm Staging | 10 | 2020 | 11244 | 0.190 |
Why?
|
Nomograms | 2 | 2020 | 236 | 0.190 |
Why?
|
Gene Expression Profiling | 8 | 2024 | 9538 | 0.190 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2021 | 85 | 0.180 |
Why?
|
DNA Primase | 1 | 2021 | 110 | 0.180 |
Why?
|
Cardia | 1 | 2020 | 61 | 0.180 |
Why?
|
Gene Frequency | 8 | 2021 | 3623 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1738 | 0.170 |
Why?
|
Sialoglycoproteins | 1 | 2021 | 315 | 0.170 |
Why?
|
Secretory Pathway | 1 | 2020 | 53 | 0.170 |
Why?
|
Early Detection of Cancer | 3 | 2024 | 3239 | 0.170 |
Why?
|
Gastric Acid | 1 | 2020 | 98 | 0.170 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2021 | 238 | 0.170 |
Why?
|
Biosynthetic Pathways | 1 | 2020 | 138 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 89 | 0.170 |
Why?
|
Light Coagulation | 1 | 2019 | 72 | 0.170 |
Why?
|
Signal Transduction | 11 | 2021 | 23645 | 0.170 |
Why?
|
Glaucoma, Neovascular | 1 | 2019 | 37 | 0.170 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2040 | 0.160 |
Why?
|
5-Methylcytosine | 1 | 2020 | 147 | 0.160 |
Why?
|
Laminin | 1 | 2021 | 405 | 0.160 |
Why?
|
Pseudogenes | 1 | 2019 | 104 | 0.160 |
Why?
|
Replication Protein A | 1 | 2019 | 54 | 0.160 |
Why?
|
Choline | 2 | 2022 | 522 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 757 | 0.160 |
Why?
|
Cation Transport Proteins | 1 | 2021 | 326 | 0.160 |
Why?
|
Proportional Hazards Models | 9 | 2024 | 12543 | 0.160 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2018 | 29 | 0.150 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 331 | 0.150 |
Why?
|
Xanthine Dehydrogenase | 1 | 2018 | 18 | 0.150 |
Why?
|
MAP Kinase Signaling System | 2 | 2024 | 1494 | 0.150 |
Why?
|
Glucosylceramidase | 1 | 2019 | 125 | 0.150 |
Why?
|
Glaucoma Drainage Implants | 1 | 2019 | 107 | 0.150 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 50 | 0.150 |
Why?
|
Life Style | 3 | 2024 | 3932 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 354 | 0.150 |
Why?
|
Catalase | 1 | 2018 | 215 | 0.150 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 749 | 0.150 |
Why?
|
Kidney Calculi | 1 | 2022 | 458 | 0.150 |
Why?
|
Platinum Compounds | 1 | 2018 | 95 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2021 | 594 | 0.150 |
Why?
|
Superoxide Dismutase | 1 | 2020 | 596 | 0.150 |
Why?
|
Riboflavin | 1 | 2018 | 107 | 0.150 |
Why?
|
Survival Rate | 8 | 2024 | 12840 | 0.150 |
Why?
|
Sulfotransferases | 1 | 2018 | 150 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2018 | 111 | 0.140 |
Why?
|
Glutathione Peroxidase | 1 | 2018 | 259 | 0.140 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2017 | 21 | 0.140 |
Why?
|
Down-Regulation | 3 | 2020 | 2937 | 0.140 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2017 | 120 | 0.140 |
Why?
|
Betaine | 1 | 2016 | 90 | 0.130 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 493 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2019 | 370 | 0.130 |
Why?
|
Computational Biology | 5 | 2021 | 3568 | 0.130 |
Why?
|
Cyclophilins | 1 | 2016 | 47 | 0.130 |
Why?
|
Helicobacter Infections | 1 | 2020 | 390 | 0.130 |
Why?
|
Phenotype | 6 | 2020 | 16726 | 0.130 |
Why?
|
Nutritional Status | 1 | 2024 | 1628 | 0.130 |
Why?
|
Circadian Clocks | 1 | 2018 | 168 | 0.130 |
Why?
|
Algorithms | 5 | 2021 | 14164 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2024 | 1890 | 0.130 |
Why?
|
Vitamin B Complex | 1 | 2018 | 299 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 707 | 0.130 |
Why?
|
Risk | 9 | 2018 | 9613 | 0.130 |
Why?
|
Estrogens | 2 | 2024 | 1536 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 4580 | 0.130 |
Why?
|
DNA Glycosylases | 1 | 2016 | 125 | 0.130 |
Why?
|
RNA, Messenger | 9 | 2022 | 12800 | 0.130 |
Why?
|
Head and Neck Neoplasms | 2 | 2022 | 2931 | 0.130 |
Why?
|
Tea | 1 | 2017 | 290 | 0.120 |
Why?
|
Dietary Supplements | 3 | 2018 | 3445 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 801 | 0.120 |
Why?
|
Mucin-1 | 1 | 2020 | 537 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2024 | 2540 | 0.120 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1613 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2016 | 313 | 0.120 |
Why?
|
Digestive System Neoplasms | 1 | 2015 | 82 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 594 | 0.120 |
Why?
|
Blood Cells | 1 | 2017 | 309 | 0.120 |
Why?
|
Nephrectomy | 1 | 2020 | 930 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.120 |
Why?
|
Binding Sites | 3 | 2018 | 6020 | 0.120 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 387 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6526 | 0.120 |
Why?
|
Prospective Studies | 8 | 2024 | 54926 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3212 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4058 | 0.120 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39348 | 0.110 |
Why?
|
Risk Assessment | 9 | 2024 | 24315 | 0.110 |
Why?
|
Quantitative Trait, Heritable | 1 | 2017 | 540 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 957 | 0.110 |
Why?
|
Epigenomics | 1 | 2020 | 960 | 0.110 |
Why?
|
Cohort Studies | 8 | 2024 | 41754 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2016 | 410 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6395 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2019 | 2954 | 0.110 |
Why?
|
Asthma | 2 | 2023 | 6291 | 0.110 |
Why?
|
Linkage Disequilibrium | 3 | 2024 | 1997 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 2015 | 251 | 0.110 |
Why?
|
Caspase 8 | 1 | 2014 | 198 | 0.110 |
Why?
|
Gastric Mucosa | 1 | 2016 | 602 | 0.110 |
Why?
|
Fas Ligand Protein | 1 | 2014 | 216 | 0.110 |
Why?
|
Bayes Theorem | 2 | 2022 | 2359 | 0.110 |
Why?
|
Fluorouracil | 1 | 2018 | 1652 | 0.110 |
Why?
|
Feces | 1 | 2020 | 1511 | 0.110 |
Why?
|
Up-Regulation | 2 | 2021 | 4146 | 0.100 |
Why?
|
Endometrial Neoplasms | 1 | 2022 | 1382 | 0.100 |
Why?
|
RNA Splicing | 1 | 2017 | 905 | 0.100 |
Why?
|
Urinary Bladder | 2 | 2020 | 1157 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 314 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1715 | 0.100 |
Why?
|
Proteomics | 3 | 2022 | 3912 | 0.100 |
Why?
|
Adult | 21 | 2024 | 223646 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2043 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2819 | 0.100 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 384 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 362 | 0.100 |
Why?
|
Ribonuclease III | 1 | 2013 | 271 | 0.100 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3833 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4786 | 0.100 |
Why?
|
BRCA2 Protein | 1 | 2016 | 802 | 0.090 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2914 | 0.090 |
Why?
|
Odds Ratio | 6 | 2020 | 9669 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 3 | 2024 | 1197 | 0.090 |
Why?
|
Aged, 80 and over | 9 | 2020 | 59629 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3445 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 859 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 842 | 0.080 |
Why?
|
Mutation | 4 | 2024 | 30238 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1194 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12252 | 0.080 |
Why?
|
Methylation | 2 | 2024 | 1078 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2024 | 5804 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 724 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3044 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1752 | 0.080 |
Why?
|
Likelihood Functions | 2 | 2022 | 994 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2885 | 0.080 |
Why?
|
Animals | 16 | 2024 | 169246 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3671 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11928 | 0.080 |
Why?
|
Folic Acid | 1 | 2015 | 1337 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2021 | 5151 | 0.080 |
Why?
|
Mice | 11 | 2024 | 82029 | 0.080 |
Why?
|
Genome, Human | 2 | 2019 | 4446 | 0.070 |
Why?
|
Cisplatin | 1 | 2014 | 1660 | 0.070 |
Why?
|
Vitamin E | 2 | 2022 | 874 | 0.070 |
Why?
|
Models, Biological | 2 | 2021 | 9495 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15832 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2448 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3433 | 0.070 |
Why?
|
HCT116 Cells | 2 | 2018 | 404 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 13053 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6082 | 0.070 |
Why?
|
Exons | 2 | 2023 | 2394 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2016 | 2982 | 0.060 |
Why?
|
Colonoscopy | 2 | 2024 | 1409 | 0.060 |
Why?
|
Comet Assay | 2 | 2015 | 74 | 0.060 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2024 | 27 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10873 | 0.060 |
Why?
|
Multifactorial Inheritance | 2 | 2023 | 1422 | 0.060 |
Why?
|
Apoptosis | 3 | 2019 | 9523 | 0.060 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3620 | 0.060 |
Why?
|
Histones | 1 | 2015 | 2601 | 0.060 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2024 | 30 | 0.060 |
Why?
|
Benzo(a)pyrene | 1 | 2024 | 28 | 0.060 |
Why?
|
Glucose Transporter Type 5 | 1 | 2023 | 13 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4249 | 0.060 |
Why?
|
Nitrosamines | 1 | 2024 | 86 | 0.060 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2024 | 101 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5341 | 0.060 |
Why?
|
Qc-SNARE Proteins | 1 | 2023 | 21 | 0.060 |
Why?
|
RNA | 2 | 2024 | 2720 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2014 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2020 | 7876 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2024 | 286 | 0.050 |
Why?
|
Cell Movement | 3 | 2022 | 5210 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Genetic Loci | 3 | 2020 | 2629 | 0.050 |
Why?
|
Estrogen Receptor beta | 1 | 2024 | 171 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2024 | 414 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 194 | 0.050 |
Why?
|
Fluorenes | 1 | 2023 | 160 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2023 | 501 | 0.050 |
Why?
|
DDT | 1 | 2021 | 32 | 0.050 |
Why?
|
Incidence | 4 | 2024 | 21538 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6231 | 0.050 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 77 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11878 | 0.050 |
Why?
|
Respiration Disorders | 1 | 2024 | 364 | 0.050 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2020 | 17 | 0.050 |
Why?
|
Particle Size | 2 | 2015 | 1649 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 10399 | 0.040 |
Why?
|
YY1 Transcription Factor | 1 | 2020 | 60 | 0.040 |
Why?
|
Immune Evasion | 1 | 2024 | 375 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9615 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6340 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2021 | 354 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2909 | 0.040 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4912 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 465 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2021 | 169 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2020 | 205 | 0.040 |
Why?
|
Databases, Nucleic Acid | 1 | 2020 | 204 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 208 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2846 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 188 | 0.040 |
Why?
|
Computer Simulation | 3 | 2018 | 6283 | 0.040 |
Why?
|
Computers | 1 | 2021 | 592 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2020 | 275 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2022 | 644 | 0.040 |
Why?
|
Drug Therapy | 1 | 2022 | 504 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2024 | 744 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 473 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 420 | 0.040 |
Why?
|
Response Elements | 1 | 2019 | 307 | 0.040 |
Why?
|
Nucleosomes | 1 | 2022 | 492 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 677 | 0.040 |
Why?
|
Malnutrition | 1 | 2024 | 632 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18349 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2018 | 3800 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 855 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2023 | 1105 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 787 | 0.040 |
Why?
|
Models, Genetic | 2 | 2018 | 3447 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 615 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 393 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 682 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 565 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1461 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 873 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1524 | 0.030 |
Why?
|
RNA Stability | 1 | 2018 | 319 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
History, 17th Century | 1 | 2016 | 108 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 996 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1660 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20760 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1169 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2019 | 753 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 938 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8080 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13090 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7598 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 718 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2020 | 65371 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1901 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 323 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21206 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2016 | 341 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 791 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1826 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2020 | 1750 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1606 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1407 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2464 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2085 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 89169 | 0.030 |
Why?
|
Child | 5 | 2024 | 80917 | 0.030 |
Why?
|
Plant Extracts | 1 | 2017 | 497 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 581 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 979 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2019 | 1304 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1679 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 60066 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1793 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1960 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2843 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1703 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1120 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13290 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19015 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 899 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1767 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2016 | 726 | 0.020 |
Why?
|
Europe | 1 | 2019 | 3436 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1761 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4260 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1259 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13671 | 0.020 |
Why?
|
Inhalation Exposure | 1 | 2014 | 432 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1674 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10099 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4793 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4120 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 385 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3343 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2381 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3347 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3611 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3114 | 0.020 |
Why?
|
Eating | 1 | 2017 | 1542 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3035 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2709 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3556 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2892 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2050 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3514 | 0.020 |
Why?
|
Visual Acuity | 1 | 2019 | 2714 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1121 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2457 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3311 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3110 | 0.020 |
Why?
|
Gastrectomy | 1 | 2014 | 693 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2911 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2021 | 3080 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2062 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3711 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1906 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2536 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2722 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2017 | 1726 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9374 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 42669 | 0.020 |
Why?
|
Weight Gain | 1 | 2018 | 2359 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10590 | 0.020 |
Why?
|
Liver | 1 | 2023 | 7577 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4620 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3814 | 0.020 |
Why?
|
Lymphocytes | 1 | 2015 | 2614 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6847 | 0.020 |
Why?
|
Urban Population | 1 | 2015 | 2046 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5027 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10266 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6124 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5458 | 0.020 |
Why?
|
Diet | 1 | 2024 | 8089 | 0.020 |
Why?
|
Heart Rate | 1 | 2018 | 4214 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10760 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11095 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14783 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4887 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5107 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15948 | 0.010 |
Why?
|
Software | 1 | 2017 | 4478 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13490 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12421 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18412 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 9015 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8543 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4916 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20227 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 81762 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40218 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36743 | 0.010 |
Why?
|
United States | 1 | 2020 | 73039 | 0.010 |
Why?
|